Top compounds associated with response to SLC23A3


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC -0.023 0.5
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.023 0.5
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA SR8278 CTRPv2 pan-cancer AAC -0.088 0.5
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Bortezomib gCSI pan-cancer AAC -0.039 0.5
mRNA linifanib CTRPv2 pan-cancer AAC -0.023 0.5
Download CSV